← All trials
NCT05184101
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 30, 2022
- Primary completion
- Dec 1, 2023
- Completion date
- Mar 1, 2024
- First posted
- Jan 11, 2022
- Last posted
- Oct 26, 2022
- Enrollment
- 100
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Australian National UniversityLead sponsor
- Australian National UniversityOverall official - principal investigator
- Australian National UniversityReponsible party - principal investigator
- University of SydneyCollaborator
- Rush UniversityCollaborator
- University of New South WalesCollaborator
- University of New South WalesCollaborator
- University of New South WalesCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.